Allan J Walkey1, Lorenzo Del Sorbo2, Carol L Hodgson3, Neill K J Adhikari4, Hannah Wunsch5, Maureen O Meade6, Elizabeth Uleryk7, Dean Hess8, Daniel S Talmor9, B Taylor Thompson8, Roy G Brower10, Eddy Fan11. 1. 1 Boston University School of Medicine, Boston, Massachusetts. 2. 2 Interdepartmental Division of Critical Care Medicine, Toronto General Hospital, Toronto, Ontario, Canada. 3. 3 Monash University, Australian and New Zealand Intensive Care Society Research Centre, Melbourne, Victoria, Australia. 4. 4 Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 5. 5 Critical Care Medicine and. 6. 6 Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. 7. 7 Hospital for Sick Children, Toronto, Ontario, Canada. 8. 8 Massachusetts General Hospital, Boston, Massachusetts. 9. 9 Beth Israel Deaconess Medical Center, Boston, Massachusetts; and. 10. 10 Johns Hopkins University School of Medicine, Baltimore, Maryland. 11. 11 Interdivisional Department of Critical Care, University of Toronto, Toronto, Ontario, Canada.
Abstract
RATIONALE: Higher positive end-expiratory pressure (PEEP) levels may reduce atelectrauma, but increase over-distention lung injury. Whether higher PEEP improves clinical outcomes among patients with acute respiratory distress syndrome (ARDS) is unclear. OBJECTIVES: To compare clinical outcomes of mechanical ventilation strategies using higher PEEP levels versus lower PEEP strategies in patients with ARDS. METHODS: We performed a systematic review and meta-analysis of clinical trials investigating mechanical ventilation strategies using higher versus lower PEEP levels. We used random effects models to evaluate the effect of higher PEEP on 28-day mortality, organ failure, ventilator-free days, barotrauma, oxygenation, and ventilation. RESULTS: We identified eight randomized trials comparing higher versus lower PEEP strategies, enrolling 2,728 patients with ARDS. Patients were 55 (±16) (mean ± SD) years old and 61% were men. Mean PEEP in the higher PEEP groups was 15.1 (±3.6) cm H2O as compared with 9.1 (±2.7) cm H2O in the lower PEEP groups. Primary analysis excluding two trials that did not use lower Vt ventilation in the lower PEEP control groups did not demonstrate significantly reduced mortality for patients receiving higher PEEP as compared with a lower PEEP (six trials; 2,580 patients; relative risk, 0.91; 95% confidence interval [CI] = 0.80-1.03). A higher PEEP strategy also did not significantly decrease barotrauma, new organ failure, or ventilator-free days when compared with a lower PEEP strategy (moderate-level evidence). Quality of evidence for primary analyses was downgraded for precision, as CIs of outcomes included estimates that would result in divergent recommendations for use of higher PEEP. Secondary analysis, including trials that did not use low Vt in low-PEEP control groups, showed significant mortality reduction for high-PEEP strategies (eight trials; 2,728 patients; relative risk, 0.84; 95% CI = 0.71-0.99), with greater mortality benefit observed for high PEEP in trials that did not use lower Vts in the low-PEEP control group (P = 0.02). Analyses stratifying by use of recruitment maneuvers (P for interaction = 0.69), or use of physiological targets to set PEEP versus PEEP/FiO2 tables (P for interaction = 0.13), did not show significant effect modification. CONCLUSIONS: Use of higher PEEP is unlikely to improve clinical outcomes among unselected patients with ARDS.
RATIONALE: Higher positive end-expiratory pressure (PEEP) levels may reduce atelectrauma, but increase over-distention lung injury. Whether higher PEEP improves clinical outcomes among patients with acute respiratory distress syndrome (ARDS) is unclear. OBJECTIVES: To compare clinical outcomes of mechanical ventilation strategies using higher PEEP levels versus lower PEEP strategies in patients with ARDS. METHODS: We performed a systematic review and meta-analysis of clinical trials investigating mechanical ventilation strategies using higher versus lower PEEP levels. We used random effects models to evaluate the effect of higher PEEP on 28-day mortality, organ failure, ventilator-free days, barotrauma, oxygenation, and ventilation. RESULTS: We identified eight randomized trials comparing higher versus lower PEEP strategies, enrolling 2,728 patients with ARDS. Patients were 55 (±16) (mean ± SD) years old and 61% were men. Mean PEEP in the higher PEEP groups was 15.1 (±3.6) cm H2O as compared with 9.1 (±2.7) cm H2O in the lower PEEP groups. Primary analysis excluding two trials that did not use lower Vt ventilation in the lower PEEP control groups did not demonstrate significantly reduced mortality for patients receiving higher PEEP as compared with a lower PEEP (six trials; 2,580 patients; relative risk, 0.91; 95% confidence interval [CI] = 0.80-1.03). A higher PEEP strategy also did not significantly decrease barotrauma, new organ failure, or ventilator-free days when compared with a lower PEEP strategy (moderate-level evidence). Quality of evidence for primary analyses was downgraded for precision, as CIs of outcomes included estimates that would result in divergent recommendations for use of higher PEEP. Secondary analysis, including trials that did not use low Vt in low-PEEP control groups, showed significant mortality reduction for high-PEEP strategies (eight trials; 2,728 patients; relative risk, 0.84; 95% CI = 0.71-0.99), with greater mortality benefit observed for high PEEP in trials that did not use lower Vts in the low-PEEP control group (P = 0.02). Analyses stratifying by use of recruitment maneuvers (P for interaction = 0.69), or use of physiological targets to set PEEP versus PEEP/FiO2 tables (P for interaction = 0.13), did not show significant effect modification. CONCLUSIONS: Use of higher PEEP is unlikely to improve clinical outcomes among unselected patients with ARDS.
Authors: Patrick Spraider; Gabriel Putzer; Robert Breitkopf; Julia Abram; Simon Mathis; Bernhard Glodny; Judith Martini Journal: BMC Anesthesiol Date: 2021-05-12 Impact factor: 2.217